Publications by authors named "Alberto Spindler"

Claim this Profile
S
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and One-Year Analysis of a Phase 2b, Open-Label, Multicenter Study.
Fabrizio De Benedetti, Inmaculada C Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J Spindler

Arthritis Care Res (Hoboken)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.
Nicolino Ruperto, Daniel J Lovell, Olga Synoverska, Carlos Abud-Mendoza, Alberto Spindler

ACR Open Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
Alessandro Consolaro, Nicolino Ruperto, Daniel J Lovell, Olga Synoverska, Carlos Abud-Mendoza, Alberto Spindler

J Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and associated factors with hospitalization in patients with systemic lupus erythematosus: Data from lupus multi-center registry in Argentina.
Lucila García, Carla Andrea Gobbi, Rosana Quintana, Belén Virasoro, Sandy Sapag Durán, Alberto Spindler

Lupus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active lupus in Argentina: Results of a multicenter and national registry.
Rosana M Quintana, Mercedes García, Lucila Garcia, Carla Gobbi, Paula Alba, Alberto Spindler

Lupus· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, Ivan Foeldvari, Alberto Spindler

Lancet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter lupus register from Argentina, the RELESSAR database: Influence of ethnicity on disease phenotype.
Mercedes A García, Paula Alba, Victor Del Campo-Perez, Susana Roverano, Rosana M Quintana, Alberto Spindler

Lupus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Nicolino Ruperto, Hermine I Brunner, Olga Synoverska, Tracy V Ting, Carlos Abud Mendoza, Alberto Spindler

Lancet· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
Nicolino Ruperto, Hermine I Brunner, César Pacheco-Tena, Ingrid Louw, Gabriel Vega-Cornejo, Alberto J Spindler

Rheumatology (Oxford)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.
Ingrid Strusberg, Eduardo Mysler, Gustavo Citera, Daniel Siri, Maria de Los Ángeles Correa, Alberto Spindler

J Clin Rheumatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
Arthur Kavanaugh, Rene R Westhovens, Kevin L Winthrop, Susan J Lee, YingMeei Tan, Alberto J Spindler

J Rheumatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
Mark C Genovese, Alberto Spindler, Akira Sagawa, Won Park, Anna Dudek

J Rheumatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Yue Yang, Jianhua Xu, Jian Xu, Xingfu Li, Jiankang Hu, Alberto J Spindler

Ther Adv Musculoskelet Dis· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
Zhanguo Li, Jiankang Hu, Chunde Bao, Xingfu Li, Xiangpei Li, Alberto J Spindler

Clin Exp Rheumatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.
Paul Emery, Juan Rondon, Janie Parrino, Yong Lin, Claudia Pena-Rossi, Alberto Spindler

Rheumatology (Oxford)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.
Mark C Genovese, Janet van Adelsberg, Chunpeng Fan, Neil M H Graham, Hubert van Hoogstraten, Alberto Spindler

Rheumatology (Oxford)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis.
Elena Sánchez, Ignacio García de la Torre, Mónica Sacnún, Mario Goñi, Guillermo Berbotto, Alberto Spindler

J Rheumatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Daniel J Wallace, Vibeke Strand, Joan T Merrill, Serghei Popa, Alberto J Spindler

Ann Rheum Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment.
Roy Fleischmann, Michael Schiff, Désirée van der Heijde, Cesar Ramos-Remus, Alberto Spindler

Arthritis Rheumatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immunogenetic characterization in psoriatic arthritis patients.
Emilce Edith Schneeberger, Gustavo Citera, Gustavo Rodríguez Gil, Amelia Granel, Alfredo Arturi, Alberto Spindler

Clin Rheumatol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Hermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, Caroline Keane, Olivier Harari, Alberto Spindler

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist.
Mark C Genovese, Désirée M van der Heijde, Edward C Keystone, Alberto J Spindler, Claude Benhamou

J Rheumatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and correlates of metabolic syndrome in patients with rheumatoid arthritis in Argentina.
María Jezabel Haye Salinas, Ana María Bertoli, Luís Lema, Carla Saucedo, Javier Rosa, Walter Spindler, Alberto Spindler

J Clin Rheumatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Eduardo F Mysler, Alberto J Spindler, Renato Guzman, Marc Bijl, David Jayne

Arthritis Rheum· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region.
David López Herráez, Manuel Martínez-Bueno, Laura Riba, Ignacio García de la Torre, Mónica Sacnún, Alberto J Spindler

Arthritis Rheum· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis